MedTrace Logo

Risk of Post-polypectomy Bleeding With Prophylactic Hemoclipping

NCT01647581 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11182

Last updated 2019-10-15

Study results available
· View outcomes & findings →

Summary

A randomized trial aimed at determining whether or not hemoclips are effective in preventing post-polypectomy bleeds on polyps that are 10mm in size or greater.

Conditions

  • Post-polypectomy Bleeding
  • Polypectomy
  • Elective Colonoscopy

Interventions

DEVICE

Hemoclip Placement

Placement of hemoclip at polypectomy site for polyps at least 1cm in size

DEVICE

NO hemoclip placement

No hemoclip placement (placebo / sham)

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Linda A Feagins · VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-01
Primary Completion
2018-11-01
Completion
2018-11-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01647581 on ClinicalTrials.gov